| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/22/2004 | US20040013723 Core is mixture of vegetable oil, flavor and artificial sweetener; shell is containing gelatin and pigment |
| 01/22/2004 | US20040013722 Gelatin soft capsule having the properties of removal of oral smell and cleaning of oral cavity |
| 01/22/2004 | US20040013721 Overcoated fluorescein particles |
| 01/22/2004 | US20040013720 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 01/22/2004 | US20040013719 Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules |
| 01/22/2004 | US20040013718 Three-dimensional body; antiinflammatory agents, autoimmune diseases; in situ response; side effect reduction |
| 01/22/2004 | US20040013717 PEG-lipid containing formulations |
| 01/22/2004 | US20040013716 Sustained release of drug antagonist; analgesic reservoir, barrier layer |
| 01/22/2004 | US20040013715 In situ applying pressure |
| 01/22/2004 | US20040013711 Adhesive patch device for preventing inner-thigh skin irritation |
| 01/22/2004 | US20040013708 Mixture containing emulsifiers, proteins and lipophilic starch; food processing |
| 01/22/2004 | US20040013706 Stress and radiation resistance; antiallergens; antiinflammatory agents |
| 01/22/2004 | US20040013704 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 01/22/2004 | US20040013703 Drug delivery shapes |
| 01/22/2004 | US20040013702 Sealed enclosure containing active materials; sustained release; drug delivery |
| 01/22/2004 | US20040013699 Antiprotozoa agents; swine; veterinary medicine |
| 01/22/2004 | US20040013697 Self-emulsifying active substance formulation and use of this formulation |
| 01/22/2004 | US20040013696 Topical applying |
| 01/22/2004 | US20040013695 Vaccines; mixture of excipients and antigens; water insoluble antacid as adjuvant; high speed dissolving |
| 01/22/2004 | US20040013693 Liquid pharmaceutical composition |
| 01/22/2004 | US20040013688 Vaccines to induce mucosal immunity |
| 01/22/2004 | US20040013675 In situ detection of tumors; diagnosis of epilepsy, Alzheimer's disease, brain disorders |
| 01/22/2004 | US20040013662 Microbubble compositions and methods for oligonucleotide delivery |
| 01/22/2004 | US20040013659 Suspension of an EPI-hNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 01/22/2004 | US20040013654 Oligonucleotide-facilitated coalescence |
| 01/22/2004 | US20040013645 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/22/2004 | US20040013644 Interferon beta-like molecules |
| 01/22/2004 | US20040013639 Injecting radiopaque material together with hydrogel having various visible dyes into the milk ducts for mapping and identifying |
| 01/22/2004 | US20040013637 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 01/22/2004 | US20040013636 Topical polymeric antimicrobial emulsion |
| 01/22/2004 | US20040013629 Spray on bandage and drug delivery system |
| 01/22/2004 | US20040013626 Controlled functionalizing of a biodegradable polymer by covalent grafting with a polysaccharide; vectors |
| 01/22/2004 | US20040013623 Chemiluminescent treatment of acne |
| 01/22/2004 | US20040013621 Transdermal delivery of antiemetics |
| 01/22/2004 | US20040013620 Antiparkinson agent, dermal penetration enhancer of a safe skin-tolerant sunscreen ester and a volatile liquid |
| 01/22/2004 | US20040013616 Oral care products comprising calcium metasilicates |
| 01/22/2004 | US20040013613 Of a poorly soluble active ingredient and at least one excipient, wherein poorly soluble active ingredient particles have average diameter, prior to inclusion in dosage form, of less than 2000 nm; rapid presentation and dissolution |
| 01/22/2004 | US20040013612 For delivering dental compositions to target sites, and for the compositions to remain at the target application area after delivery |
| 01/22/2004 | US20040013611 Suspension aerosol formulations |
| 01/22/2004 | US20040011644 For selectively removing one type of molecule from a medium while leaving other types of molecules in the medium using forces unrelated to hydrophic forces, which nonspecifically apply to all lipophilic molecules |
| 01/22/2004 | US20040011356 Medicament respiratory delivery device and cartridge |
| 01/22/2004 | DE20318151U1 Ramipril enthaltende feste pharmazeutische Zusammensetzungen Ramipril containing solid pharmaceutical compositions |
| 01/22/2004 | DE20023356U1 Stable matrix-type controlled release compositions for oral use comprise yellow or red iron sesquioxide |
| 01/22/2004 | DE10232139A1 Mit Nukleinsäuren und Nukleinsäurederivaten beschichteter metallischer Gegenstand, Verfahren zu dessen Herstellung und dessen Verwendung With nucleic acids and nucleic acid derivatives of coated metallic object, process for its preparation and its use |
| 01/22/2004 | DE10230769A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren New pharmaceutical compositions based on new anticholinergics and PDE IV inhibitors |
| 01/22/2004 | DE10230751A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern New pharmaceutical compositions based on new anticholinergics and EGFR kinase inhibitors |
| 01/22/2004 | DE10230750A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten New pharmaceutical compositions based on new Anticholonergika and NK1 receptor antagonists |
| 01/22/2004 | DE10230558A1 Kombinationstherapie und Mittel zu seiner Durchführung Combination therapy and means for its implementation |
| 01/22/2004 | DE10230223A1 Mikropartikel mit CD28-spezifischen monoklonalen Antikörpern Microparticles with CD28-specific monoclonal antibodies |
| 01/22/2004 | DE10228680A1 Grundlage für transdermale Formulierungen (PTF) Basis for transdermal formulations (PTF) |
| 01/22/2004 | DE10228179A1 Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen Dosage form for oral administration of active ingredients, vitamins and / or nutrients |
| 01/22/2004 | CA2805600A1 Medicaments containing vardenafil hydrochloride trihydrate |
| 01/22/2004 | CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | CA2782498A1 Tablet composition containing kampo medicinal extract and its manufacturing process |
| 01/22/2004 | CA2532324A1 Microbubble compositions, and methods for preparing and using same |
| 01/22/2004 | CA2492722A1 Production method of coated preparations |
| 01/22/2004 | CA2492488A1 Liquid dosage compositions of stable nanoparticulate active agents |
| 01/22/2004 | CA2492485A1 Stable pharmaceutical composition comprising erythropoietin |
| 01/22/2004 | CA2492374A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 01/22/2004 | CA2492143A1 Methods and compositions for preventing oxidative degradation of proteins |
| 01/22/2004 | CA2492089A1 Delivery system for pharmaceutical agents |
| 01/22/2004 | CA2492029A1 Transdermal botulinum toxin compositions |
| 01/22/2004 | CA2490976A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 01/22/2004 | CA2488923A1 Oral care capsules |
| 01/21/2004 | EP1382687A1 Process for producing isomaltose and use thereof |
| 01/21/2004 | EP1382628A1 Biodegradable phase separated segmented/block co-polyesters |
| 01/21/2004 | EP1382350A1 Preventives for postoperative recurrence of premenopausal breast cancer |
| 01/21/2004 | EP1382346A1 Conditioned medium and diffusible biological product produced by incubating entrapped cells |
| 01/21/2004 | EP1382342A1 Use of compositiosn comprising glycyrrhetinic acid and salicylic acid for acne treatment |
| 01/21/2004 | EP1382341A1 Use of compositions comprising glycyrrhetinic acid and benzoyl peroxide for acne treatment |
| 01/21/2004 | EP1382338A1 Controlled release tablet comprising tilidine and a photoprotectant |
| 01/21/2004 | EP1382337A1 Novel formulation containing paroxetine |
| 01/21/2004 | EP1382331A1 A pharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluids |
| 01/21/2004 | EP1382330A1 Aqueous-Based pharmaceutical composition |
| 01/21/2004 | EP1382329A1 Compositions for photoprotection comprising a flavonoid |
| 01/21/2004 | EP1382263A2 Use of calcium in acidic oral compositions for the reduction of tooth erosion caused by acid |
| 01/21/2004 | EP1381620A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 01/21/2004 | EP1381455A1 Stable aqueous colloidal dispersion, method for preparing same |
| 01/21/2004 | EP1381432A2 Hsa-free formulations of interferon-beta |
| 01/21/2004 | EP1381411A2 Apparatus for the delivery of drugs or gene therapy into a patient's vasculature and methods of use |
| 01/21/2004 | EP1381408A2 Modular infusion device and method |
| 01/21/2004 | EP1381393A1 Microparticle protection of therapeutic agents |
| 01/21/2004 | EP1381391A1 Vaccines including as an adjuvant type 1 ifn and processes related thereto |
| 01/21/2004 | EP1381390A2 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
| 01/21/2004 | EP1381386A2 Novel mixtures of microbial enzymes |
| 01/21/2004 | EP1381385A1 Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability |
| 01/21/2004 | EP1381382A2 Methods and compositions for the treatment of diseases of the eye |
| 01/21/2004 | EP1381381A1 Patch for transcutaneous immunization |
| 01/21/2004 | EP1381376A2 In vivo use of water absorbent polymers |
| 01/21/2004 | EP1381374A1 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel |
| 01/21/2004 | EP1381368A2 Compositions containing imidazotriazinone for nasal application |
| 01/21/2004 | EP1381367A1 Aripiprazole oral solution |
| 01/21/2004 | EP1381362A2 Pharmaceutical composition comprising clavulanic acid |
| 01/21/2004 | EP1381358A1 Solid pharmaceutical composition comprising 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp |
| 01/21/2004 | EP1381353A2 Ipratropium formulation for pulmonary inhalation |
| 01/21/2004 | EP1381352A1 Transdermal patch for administering fentanyl |
| 01/21/2004 | EP1381351A1 Method for the continuous production of medicaments for inhalation |
| 01/21/2004 | EP1381346A2 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 01/21/2004 | EP1381344A2 Novel vaccine |
| 01/21/2004 | EP1191942B1 Use of antileukoprotease for the treatment of endometriosis |